Kalyra Pharmaceuticals Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
Kalyra Pharmaceuticals General Information
Description
Developer of healthcare drug products designed to support the unmet needs in the area of pain management, anti-infectives, and fibrosis. The company's medicines are potent, non-opioid, non-NSAID pain therapeutics that are made using modified molecules that retain the efficacy of commonly used medications while reducing or eliminating unwanted side effects and safety concerns, enabling doctors to improve patient treatment outcomes.
Contact Information
Website
www.kalyrapharma.comCorporate Office
- 10835 Road To The Cure
- Suite 205
- San Diego, CA 92121
- United States
Corporate Office
- 10835 Road To The Cure
- Suite 205
- San Diego, CA 92121
- United States
Kalyra Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 09-Jan-2024 | 000.00 | Completed | Out of Business | ||
| 6. Grant | 31-Dec-2017 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series B) | 21-Dec-2017 | 00.00 | 000.00 | 0000 | Completed | Generating Revenue |
| 4. Grant | 01-Jan-2017 | 000000 | 00.000 | Completed | Generating Revenue | |
| 3. Grant | 01-Jan-2016 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Grant | 01-Jul-2015 | $2.47M | $6.18M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 08-Nov-2013 | $6.18M | $6.18M | 0000 | Completed | Generating Revenue |
Kalyra Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.00 | 00.00 | 00 | 00.00 | 000 | ||
| Series A | 00,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Kalyra Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kalyra Pharmaceuticals Patents
Kalyra Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9447026-B2 | Bicyclic analgesic compounds | Active | 14-Mar-2013 | 000000000 | 0 |
Kalyra Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Kalyra Pharmaceuticals FAQs
-
When was Kalyra Pharmaceuticals founded?
Kalyra Pharmaceuticals was founded in 2011.
-
Who is the founder of Kalyra Pharmaceuticals?
Kevin Bunker Ph.D, Ned Israelsen JD, Cam Garner, Brian Dorsey, and Susan Dubé are the founders of Kalyra Pharmaceuticals.
-
Where is Kalyra Pharmaceuticals headquartered?
Kalyra Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Kalyra Pharmaceuticals?
Kalyra Pharmaceuticals has 11 total employees.
-
What industry is Kalyra Pharmaceuticals in?
Kalyra Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Kalyra Pharmaceuticals a private or public company?
Kalyra Pharmaceuticals is a Private company.
-
What is Kalyra Pharmaceuticals’s current revenue?
The current revenue for Kalyra Pharmaceuticals is 000000.
-
How much funding has Kalyra Pharmaceuticals raised over time?
Kalyra Pharmaceuticals has raised $10.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
